Stock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price

Stock Track05-13

Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.

The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.

Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151767868?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 01:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151767868","market":"us","top_or_hot":-1,"title":"Stock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price","media":"Stock Track","content":"<p>Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.</p><p>The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.</p><p>Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-13 01:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.</p><p>The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.</p><p>Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1151767868","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151767868","pubTimestamp":1778608535,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.The surge was driven by multiple...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"个股追踪|奥斯卡健康盘中大涨5.00%公司重申指引瑞银上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151767868","isCrawlerRequest":true}